New York, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Pharmaceutical API Manufacturing Global Market Report 2023" - https ...

RPG Life Sciences plans to deploy Rs. 500 crore over the next 12 months to expand its manufacturing footprint and Active ...

New drug approvals, generic expansion, high-potency API demand, and the continued globalization of pharmaceutical manufacturing present lucrative business opportunities Small Molecule API ...

RPG Active Pharma strengthens its API presence by acquiring Raghava Life Sciences' API business, enhancing growth and ...

Manufacturers and contract development and manufacturing organizations are developing processes and facilities to meet growing specialty API demand. For decades, APIs, the foundation of the ...

China and India, which are the largest producers of APIs for the U.S. drug supply, also account for most of the FDA regulatory actions. Not only do quality problems at Chinese and Indian firms raise ...

CDMO Olon is continuing its expansion binge with a deal to buy an API plant in India that supplies ingredients to Novartis. The Italian generic drug and API maker said Tuesday that it is buying an API ...

RPG Life Sciences is acquiring Raghava Life Sciences' API business for ₹135 crore, enhancing its manufacturing and product portfolio.

Efficiency and adaptability are crucial in the ever-evolving manufacturing industry. As manufacturers adopt advanced technologies like IoT, AI, and cloud computing, the need for seamless integration ...